Literature DB >> 13403156

Mycobacterium ulcerans infections; response to chemotherapy in mice.

W H FELDMAN, A G KARLSON.   

Abstract

Entities:  

Keywords:  MYCOBACTERIUM/infections

Mesh：

Year:  1957        PMID： 13403156     DOI： 10.1164/artpd.1957.75.2.266

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  8 in total

1.  SURVEY OF RECENT LEPROSY RESEARCH.

Authors:  W F KIRCHHEIMER
Journal:  Public Health Rep       Date:  1964-06       Impact factor: 2.792

2.  [On a skin infection caused by Mycobacterium marinum or balnei].

Authors:  H HAUSS; C SIMON
Journal:  Arch Klin Exp Dermatol       Date:  1963

3.  [The so-called atypical mycobacteria].

Authors:  E FREERKSEN
Journal:  Klin Wochenschr       Date:  1960-04-01

4.  Mycobacterium ulcerans; pathogenesis of infection in mice, including determinations of dermal temperatures.

Authors:  W H FELDMAN; A G KARLSON; J F HERRICK
Journal:  Am J Pathol       Date:  1957 Nov-Dec       Impact factor: 4.307

Review 5.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

6.  Activities of several antimicrobials against Mycobacterium ulcerans infection in mice.

Authors:  H Dega; J Robert; P Bonnafous; V Jarlier; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.

Authors:  Herve Dega; Abdelhalim Bentoucha; Jerome Robert; Vincent Jarlier; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 8.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.